MedicaNatumin AB (publ) acquires the sales rights to a product portfolio from ArconNorway AS
MedicaNatumin subsidiary Vitalkost AS has acquired the sales rights to a product portfolio from Norwegian Arcon Norway AS. The portfolio consists of several brands including the dietary supplement series Femarelle.
For Vitalkost, the acquisition offers opportunities to continue the strong growth path experienced in the Norwegian market, where the company currently has a position as one of the leading companies in the self-care industry.
Vitalkost will now have access to a wider range of products and the opportunity to reach a strong target group consisting of almost one million women, mainly through the leading brand Femarelle. The product portfolio is expected to have a turnover of approximately 15 MNOK in 2020. With investments in marketing and distribution we predict continued revenue growth in the coming years.
“Our growth strategy includes both organic growth and growth through acquisitions. We strengthen Vitalkost’s position even further in the Norwegian market. Thus, enabling continued positive impact on sales and results for 2021, through the acquisition of the sales rights to the product portfolio from Arcon” says Ulrika Albers, CEO MedicaNatumin.
“Femarelle is a strong product in the Norwegian market where Arcon has succeeded in recent years to build a stable market position for the product range. I believe that Vitalkost can continue to develop the sales of Femarelle and other products in the portfolio even further through the network Vitalkost has today,” says Totto Solvang, General manager Vitalkost.
“After almost 40 years as a supplier of health food products, I now choose to leave this industry. Vitalkost is the perfect company to continue the sale of Arcon’s products. Their market position and knowledge in the industry will certainly give the products a boost in the coming years,” says Johnny Hamre, owner and CEO of Arcon Norway AS.
Femarelle consists of a series of hormone-free dietary supplements recommended worldwide by leading gynecologists. It is a very good option for women who are approaching, are experiencing, or have passed menopause. Femarelle have been sold for over 20 years worldwide. The main ingredient in Femarelle is DT56a, which is extracted by fermentation and treatment of soybeans. The products have been developed and studied in close collaboration with world-leading experts in women’s health.
About the remaining products in the Arcon-Norway AS portfolio
Brizo® is a novel soybean extract that supports men’s prostate and urinary health, providing relief for bothersome urinary symptoms throughout the day and especially at night.
Z Skin Repair is a skin care line with the patented enzyme Zonase, an enzyme with well-documented, caring and repairing properties for all skin types. Particularly effective against sore, dry and irritated skin.
Arcon Tisane is a line of nutritional supplement with fenugreek seed concentrate, vitamins and trace elements developed to help those who suffer from hair loss.
Caviar is a range of natural skin care products with real caviar.
For further information, please contact
Totto Solvang, Managing director Vitalkost AS
Ulrika Albers, CEO MedicaNatumin AB (publ)
This information is information that MedicaNatumin AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on November 26th, 2020.
MedicaNatumin develops, manufactures, and markets health and beauty products based on innovative ingredients and solid research. The company’s patented platforms are developed by its own research group in collaboration with Karolinska and Sahlgrenska institutes. MedicaNatumin’s leading brands in the categories of dietary supplements, medical devices and dermatological and cosmetic products are sold largely on the Nordic market but also to consumers around the world. We also have distribution rights for a number of popular organic foods and skin care products on the Norwegian market. Head office and production are located in Jönköping and Habo respectively and subsidiary in Tønsberg. MedicaNatumin AB (publ) is listed on the Nordic Growth Market (NGM) Nordic SME.